News & Articles
25
Selected Filters:
Industry News
NGS-Based MammaPrint BluePrint Kit Enhances Access to Personalized Treatment for Breast Cancer Patients in Europe
New RNA-sequencing kit will improve treatment management decisions for breast cancer patients
Industry News
Agendia Collaborates with Institut Curie for MammaPrint BluePrint Breast Cancer Kit Co-Validation Study
Institut Curie is one of an increasing number of major European cancer centers to become a co-validation partner for the new NGS-based MammaPrint BluePrint Kit
Industry News
Influencing How Breast Cancer Patients are Treated
Industry News
Agendia Highlights Study Showing MammaPrint/BluePrint Tests Predict Response to Current Breast Cancer Chemotherapy and Targeted Therapy Regimens
Researchers present data at breast cancer symposium showing MammaPrint/BluePrint can identify women who benefit from chemotherapy and targeted dual anti-HER2 drug treatment before surgery
